A citation-based method for searching scientific literature

Zhening Zhang, Tong Xie, Xiaotian Zhang, Changsong Qi, Lin Shen, Zhi Peng. Chin J Cancer Res 2020
Times Cited: 12







List of co-cited articles
28 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Yelena Y Janjigian, Kohei Shitara, Markus Moehler, Marcelo Garrido, Pamela Salman, Lin Shen, Lucjan Wyrwicz, Kensei Yamaguchi, Tomasz Skoczylas, Arinilda Campos Bragagnoli,[...]. Lancet 2021
401
33

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.
Charles S Fuchs, Toshihiko Doi, Raymond W Jang, Kei Muro, Taroh Satoh, Manuela Machado, Weijing Sun, Shadia I Jalal, Manish A Shah, Jean-Phillipe Metges,[...]. JAMA Oncol 2018
941
33

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
25

Immune checkpoint inhibitors in malignant lymphoma: Advances and perspectives.
Ningjing Lin, Yuqin Song, Jun Zhu. Chin J Cancer Res 2020
15
25

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.
Robert M Samstein, Chung-Han Lee, Alexander N Shoushtari, Matthew D Hellmann, Ronglai Shen, Yelena Y Janjigian, David A Barron, Ahmet Zehir, Emmet J Jordan, Antonio Omuro,[...]. Nat Genet 2019
25

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
25

The Methods of Lymph Node Examination Make a Difference to Node Staging and Detection of N3b Node Status for Gastric Cancer.
Xinhua Chen, Yuehong Chen, Yanfeng Hu, Tian Lin, Jun Luo, Tuanjie Li, Tao Li, HuiLin Huang, Yu Zhu, Tingting Li,[...]. Front Oncol 2020
9
22

Implications of clinical research on adjuvant chemotherapy for gastric cancer: Where to go next?
Xinhua Chen, Hao Liu, Guoxin Li, Jiang Yu. Chin J Cancer Res 2019
10
20

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
E C Smyth, M Verheij, W Allum, D Cunningham, A Cervantes, D Arnold. Ann Oncol 2016
865
16



Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.
Akihito Kawazoe, Takeshi Kuwata, Yasutoshi Kuboki, Kohei Shitara, Akiko Kawano Nagatsuma, Masaaki Aizawa, Takayuki Yoshino, Toshihiko Doi, Atsushi Ohtsu, Atsushi Ochiai. Gastric Cancer 2017
133
16

Positive Status of Epstein-Barr Virus as a Biomarker for Gastric Cancer Immunotherapy: A Prospective Observational Study.
Tong Xie, Yiqiang Liu, Zhening Zhang, Xiaotian Zhang, Jifang Gong, Changsong Qi, Jian Li, Lin Shen, Zhi Peng. J Immunother 2020
28
16


Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).
Shota Fukuoka, Hiroki Hara, Naoki Takahashi, Takashi Kojima, Akihito Kawazoe, Masako Asayama, Takako Yoshii, Daisuke Kotani, Hitomi Tamura, Yuichi Mikamoto,[...]. J Clin Oncol 2020
252
16

Challenges of evaluating immunotherapy efficacy in solid tumors.
Rilan Bai, Wenqian Li, Nawen Du, Jiuwei Cui. Chin J Cancer Res 2019
5
40

Advances and challenges in immunotherapy of small cell lung cancer.
Hanfei Guo, Lingyu Li, Jiuwei Cui. Chin J Cancer Res 2020
12
16

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
Nadeem Riaz, Jonathan J Havel, Vladimir Makarov, Alexis Desrichard, Walter J Urba, Jennifer S Sims, F Stephen Hodi, Salvador Martín-Algarra, Rajarsi Mandal, William H Sharfman,[...]. Cell 2017
927
16


Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
Kohei Shitara, Eric Van Cutsem, Yung-Jue Bang, Charles Fuchs, Lucjan Wyrwicz, Keun-Wook Lee, Iveta Kudaba, Marcelo Garrido, Hyun Cheol Chung, Jeeyun Lee,[...]. JAMA Oncol 2020
302
16

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
Suzanne L Topalian, F Stephen Hodi, Julie R Brahmer, Scott N Gettinger, David C Smith, David F McDermott, John D Powderly, Richard D Carvajal, Jeffrey A Sosman, Michael B Atkins,[...]. N Engl J Med 2012
16

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.
Kohei Shitara, Mustafa Özgüroğlu, Yung-Jue Bang, Maria Di Bartolomeo, Mario Mandalà, Min-Hee Ryu, Lorenzo Fornaro, Tomasz Olesiński, Christian Caglevic, Hyun C Chung,[...]. Lancet 2018
682
16

Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
Thierry André, Kai-Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis Punt, Denis Smith, Rocio Garcia-Carbonero, Manuel Benavides, Peter Gibbs,[...]. N Engl J Med 2020
660
16

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.
Denis L Jardim, Aaron Goodman, Debora de Melo Gagliato, Razelle Kurzrock. Cancer Cell 2021
146
16

Robust enumeration of cell subsets from tissue expression profiles.
Aaron M Newman, Chih Long Liu, Michael R Green, Andrew J Gentles, Weiguo Feng, Yue Xu, Chuong D Hoang, Maximilian Diehn, Ash A Alizadeh. Nat Methods 2015
16

Current status of immune checkpoint inhibitors for gastric cancer.
Koji Kono, Shotaro Nakajima, Kosaku Mimura. Gastric Cancer 2020
66
16

PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome.
Hashem O Alsaab, Samaresh Sau, Rami Alzhrani, Katyayani Tatiparti, Ketki Bhise, Sushil K Kashaw, Arun K Iyer. Front Pharmacol 2017
824
16

Metformin and reduced risk of cancer in diabetic patients.
Josie M M Evans, Louise A Donnelly, Alistair M Emslie-Smith, Dario R Alessi, Andrew D Morris. BMJ 2005
8

Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Hae Jin Kim, SooJin Lee, Ki Hong Chun, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Young Seol Kim, Jeong-Taek Woo, Moon-Suk Nam, Sei Hyun Baik,[...]. Medicine (Baltimore) 2018
33
8

Chinese guidelines for diagnosis and treatment of gastric cancer 2018 (English version).
National Health Commission Of The People's Republic Of China. Chin J Cancer Res 2019
59
8

Diabetes mellitus and gastric carcinoma: Is there an association?
Sathiya P Marimuthu, Paari Vijayaragavan, Kirsten B Moysich, Vijayvel Jayaprakash. J Carcinog 2011
18
8

The foregut theory as a possible mechanism of action for the remission of type 2 diabetes in low body mass index patients undergoing subtotal gastrectomy for gastric cancer.
Yeongkeun Kwon, Abraham Abdemur, Emanuele Lo Menzo, Sungsoo Park, Samuel Szomstein, Raul J Rosenthal. Surg Obes Relat Dis 2014
21
8

Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II-III randomized trial.
Kan Xue, Xiangji Ying, Zhaode Bu, Aiwen Wu, Zhongwu Li, Lei Tang, Lianhai Zhang, Yan Zhang, Ziyu Li, Jiafu Ji. Chin J Cancer Res 2018
18
8

A Metformin-Responsive Metabolic Pathway Controls Distinct Steps in Gastric Progenitor Fate Decisions and Maturation.
Zhi-Feng Miao, Mahliyah Adkins-Threats, Joseph R Burclaff, Luciana H Osaki, Jing-Xu Sun, Yan Kefalov, Zheng He, Zhen-Ning Wang, Jason C Mills. Cell Stem Cell 2020
17
8

Improvement of type 2 diabetes mellitus after gastric cancer surgery: short-term outcome analysis after gastrectomy.
Ji Yeong An, Yoo Min Kim, Min Ah Yun, Byeong Hee Jeon, Sung Hoon Noh. World J Gastroenterol 2013
24
8

Cancer survival in the elderly: effects of socio-economic factors and health care system features (ELDCARE project).
Marina Vercelli, Roberto Lillini, Riccardo Capocaccia, Andrea Micheli, Jan Willem Coebergh, Mike Quinn, Carmen Martinez-Garcia, Alberto Quaglia. Eur J Cancer 2006
49
8

Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.
Manami Inoue, Motoki Iwasaki, Tetsuya Otani, Shizuka Sasazuki, Mitsuhiko Noda, Shoichiro Tsugane. Arch Intern Med 2006
393
8

The global implications of diabetes and cancer.
Yuankai Shi, Frank B Hu. Lancet 2014
226
8

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.
Rebecca K Simmons, Justin B Echouffo-Tcheugui, Stephen J Sharp, Lincoln A Sargeant, Kate M Williams, A Toby Prevost, Ann Louise Kinmonth, Nicholas J Wareham, Simon J Griffin. Lancet 2012
147
8

Tackling the global diabetes burden: will screening help?
Michael M Engelgau, Edward W Gregg. Lancet 2012
12
8

Impact of diabetes mellitus on outcomes in patients with colon cancer.
Jeffrey A Meyerhardt, Paul J Catalano, Daniel G Haller, Robert J Mayer, John S Macdonald, Al B Benson, Charles S Fuchs. J Clin Oncol 2003
270
8

Immune-mediated antitumor effect by type 2 diabetes drug, metformin.
Shingo Eikawa, Mikako Nishida, Shusaku Mizukami, Chihiro Yamazaki, Eiichi Nakayama, Heiichiro Udono. Proc Natl Acad Sci U S A 2015
334
8

Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis.
Xiuwen Geng, Hao Liu, Tian Lin, Yanfeng Hu, Hao Chen, Liying Zhao, Tingyu Mou, Xiaolong Qi, Jiang Yu, Guoxin Li. Cancer Med 2016
19
8

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Ping-Ting Zhou, Bo Li, Fu-Rao Liu, Mei-Chao Zhang, Qian Wang, Yan-Yan Li, Ci Xu, Yuan-Hua Liu, Yuan Yao, Dong Li. Oncotarget 2017
41
8

Gastric Cancer Heterogeneity and Clinical Outcomes.
Rachel E Sexton, Mohammed Najeeb Al Hallak, Md Hafiz Uddin, Maria Diab, Asfar S Azmi. Technol Cancer Res Treat 2020
8
12


Socioeconomic status and survival of gastric cancer patients.
V Fontana, A Decensi, M A Orengo, S Parodi, R Torrisi, R Puntoni. Eur J Cancer 1998
37
8

Patterns of initial recurrence in completely resected gastric adenocarcinoma.
Michael D'Angelica, Mithat Gonen, Murray F Brennan, Alan D Turnbull, Manjit Bains, Martin S Karpeh. Ann Surg 2004
442
8

The antidiabetic drug metformin inhibits gastric cancer cell proliferation in vitro and in vivo.
Kiyohito Kato, Jian Gong, Hisakazu Iwama, Akira Kitanaka, Joji Tani, Hisaaki Miyoshi, Kei Nomura, Shima Mimura, Mitsuyoshi Kobayashi, Yuuichi Aritomo,[...]. Mol Cancer Ther 2012
164
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.